Compounds > tretazicar
Page last updated: 2024-08-26

tretazicar and 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride

tretazicar has been researched along with 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyle, RG; Travers, S1

Reviews

1 review(s) available for tretazicar and 4-(3-(2-nitro-1-imidazolyl)-propylamino)-7-chloroquinoline hydrochloride

ArticleYear
Hypoxia: targeting the tumour.
    Anti-cancer agents in medicinal chemistry, 2006, Volume: 6, Issue:4

    Topics: Anthraquinones; Antineoplastic Agents; Aziridines; Benzoquinones; Cell Hypoxia; Clinical Trials, Phase III as Topic; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indolequinones; Neoplasms; Prodrugs; Quinolines; Radiation-Sensitizing Agents; Tirapazamine; Triazines

2006